These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36169035)

  • 1. An interpretable machine learning model for selectivity of small-molecules against homologous protein family.
    Vangala SR; Bung N; Krishnan SR; Roy A
    Future Med Chem; 2022 Oct; 14(20):1441-1453. PubMed ID: 36169035
    [No Abstract]   [Full Text] [Related]  

  • 2. Multimodal multi-task deep neural network framework for kinase-target prediction.
    Hua Y; Luo L; Qiu H; Huang D; Zhao Y; Liu H; Lu T; Chen Y; Zhang Y; Jiang Y
    Mol Divers; 2023 Dec; 27(6):2491-2503. PubMed ID: 36369613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches.
    Wu Z; Lei T; Shen C; Wang Z; Cao D; Hou T
    J Chem Inf Model; 2019 Nov; 59(11):4587-4601. PubMed ID: 31644282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning Models Based on Molecular Fingerprints and an Extreme Gradient Boosting Method Lead to the Discovery of JAK2 Inhibitors.
    Yang M; Tao B; Chen C; Jia W; Sun S; Zhang T; Wang X
    J Chem Inf Model; 2019 Dec; 59(12):5002-5012. PubMed ID: 31746601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved machine learning models for predicting selective compounds.
    Ning X; Walters M; Karypis G
    J Chem Inf Model; 2012 Jan; 52(1):38-50. PubMed ID: 22107358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications.
    Feinstein J; Shi W; Ramanujam J; Brylinski M
    Methods Mol Biol; 2021; 2266():299-312. PubMed ID: 33759134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions.
    Rodríguez-Pérez R; Bajorath J
    J Comput Aided Mol Des; 2020 Oct; 34(10):1013-1026. PubMed ID: 32361862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GeneralizedDTA: combining pre-training and multi-task learning to predict drug-target binding affinity for unknown drug discovery.
    Lin S; Shi C; Chen J
    BMC Bioinformatics; 2022 Sep; 23(1):367. PubMed ID: 36071406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Machine Intelligence in Compound Cell Activity Classification.
    Fan Y; Zhang Y; Hua Y; Wang Y; Zhu L; Zhao J; Yang Y; Chen X; Lu S; Lu T; Chen Y; Liu H
    Mol Pharm; 2019 Nov; 16(11):4472-4484. PubMed ID: 31580683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity Comparison across Multiple Machine Learning Algorithms Using over 5000 Datasets for Drug Discovery.
    Lane TR; Foil DH; Minerali E; Urbina F; Zorn KM; Ekins S
    Mol Pharm; 2021 Jan; 18(1):403-415. PubMed ID: 33325717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritizing Virtual Screening with Interpretable Interaction Fingerprints.
    Fassio AV; Shub L; Ponzoni L; McKinley J; O'Meara MJ; Ferreira RS; Keiser MJ; de Melo Minardi RC
    J Chem Inf Model; 2022 Sep; 62(18):4300-4318. PubMed ID: 36102784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Deep-Learning View of Chemical Space Designed to Facilitate Drug Discovery.
    Maragakis P; Nisonoff H; Cole B; Shaw DE
    J Chem Inf Model; 2020 Oct; 60(10):4487-4496. PubMed ID: 32697578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assisting Multitargeted Ligand Affinity Prediction of Receptor Tyrosine Kinases Associated Nonsmall Cell Lung Cancer Treatment with Multitasking Principal Neighborhood Aggregation.
    Nakarin F; Boonpalit K; Kinchagawat J; Wachiraphan P; Rungrotmongkol T; Nutanong S
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of active molecules against Mycobacterium tuberculosis through machine learning.
    Ye Q; Chai X; Jiang D; Yang L; Shen C; Zhang X; Li D; Cao D; Hou T
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Multitask Deep Learning Practical for Pharma?
    Ramsundar B; Liu B; Wu Z; Verras A; Tudor M; Sheridan RP; Pande V
    J Chem Inf Model; 2017 Aug; 57(8):2068-2076. PubMed ID: 28692267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional Networks.
    Montanari F; Kuhnke L; Ter Laak A; Clevert DA
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31877719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ComABAN: refining molecular representation with the graph attention mechanism to accelerate drug discovery.
    Yan H; Xie Y; Liu Y; Yuan L; Sheng R
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35998925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying Deep Neural Networks and Ensemble Machine Learning Methods to Forecast Airborne
    Zewdie GK; Lary DJ; Levetin E; Garuma GF
    Int J Environ Res Public Health; 2019 Jun; 16(11):. PubMed ID: 31167504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Group-Contribution Concept and Graph Neural Networks Toward Interpretable Molecular Property Models.
    Aouichaoui ARN; Fan F; Mansouri SS; Abildskov J; Sin G
    J Chem Inf Model; 2023 Feb; 63(3):725-744. PubMed ID: 36716461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.